Investigating the spread of isoniazid-resistant tuberculosis in Haiti

Sentinel populations and transmission hotspots of isoniazid-resistant tuberculosis

NIH-funded research Weill Medical Coll of Cornell Univ · NIH-10887506

This study is looking at how isoniazid-resistant tuberculosis spreads among teenagers in Haiti, using special tools to find out where it’s happening, so we can come up with better ways to help keep everyone healthy.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-10887506 on NIH RePORTER

What this research studies

This research focuses on understanding the transmission patterns of isoniazid-resistant tuberculosis (INHr-TB) in Haiti, particularly among adolescents. The project utilizes advanced techniques such as whole genome sequencing and geographic information systems (GIS) to map and analyze the spread of this drug-resistant form of TB. By identifying hotspots of transmission outside of households, the research aims to inform better public health strategies and interventions. The principal investigator, Dr. Kathleen Walsh, has extensive experience in treating drug-resistant TB and has trained local healthcare teams in research methodologies.

Who could benefit from this research

Good fit: Ideal candidates for this research include adolescents and young adults in Haiti who are at risk of or affected by isoniazid-resistant tuberculosis.

Not a fit: Patients who do not reside in Haiti or who are not part of the adolescent population may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for controlling and preventing the spread of drug-resistant tuberculosis, ultimately saving lives.

How similar studies have performed: Previous research has shown success in using molecular epidemiology and GIS mapping to track and control infectious diseases, suggesting that this approach could be effective for tuberculosis as well.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.